Pascal Soriot became CEO of the pharmaceutical multinational company in October 2012 and has since presided over a remarkable turnaround. Soriot led the revival of AstraZeneca’s reputation for research and development while rebuffing a takeover attempt by rival Pfizer worth $118 billion. Soriot studied veterinary medicine at the École Nationale vétérinaire d'Alfort at Maisons-Alfort in […]
CEO Today Online and CEO Today magazine are dedicated to providing CEOs and C-level executives with the latest corporate developments, business news and technological innovations.
